Use of hypericum as antidepressant

BMJ

Volumn 320, Issue 7242, 2000, Pages 1141-

  Thornett, Andrew ^a   Walton, Mike ^b   Vickers, Andrew ^c   Gorski, Tim ^d   Menkes, David B ^e   Balfour, Peter ^f   Philipp, Michael ^g   Kohnen, Ralf ^h   Hiller, Karl O ⁱ  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Harvey Croup Practice   (United Kingdom)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Dunedin Hospital ^*  (United States)

^e DUNEDIN HOSPITAL   (New Zealand)

^f WEST CUMBERLAND HOSPITAL   (United Kingdom)

^g Bezirkskrankenhaus Landshut   (Germany)

^h IMEREM Institute for Medical Research Management and Biometrics GmbH   (Germany)

ⁱ Steiner Arzneimittel   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007664743     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.320.7242.1141/a     Document Type: Letter

References (14)

1. Philipp M, Kohnen R, Hiller K-O. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks [with commentary by K Linde and M Berner]. BMJ 1999; 319: 1534–1539. (11 December 1999.)
2. Zollman C, Vickers A. ABC of complementary medicine: Complementary medicine and the doctor. BMJ 1999; 319: 1538–1561.
3. Philipp M, Kohnen R, Hiller K-O. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks [with commentary by K Linde and M Berner]. BMJ 1999; 319: 1534–1539. (11 December.)
4. Walter G, Rey J. The relevance of herbal treatments for psychiatric practice. Aust N Z J Psychiatry 1999; 33: 482–489.
5. Hotopf M. Review: St. John's wort is more effective than placebo for treating depressive disorders. Evidence-Based Medicine 1999; May/June: 82.
6. Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Muller WE. Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci 1998; 63: 499–510.
7. Martonfi P, Repcak M. Secondary metabolites during flower ontogenesis of Hypericum Perforatum. Zahradnictvi 1994; 21: 37–44.
8. Philipp M, Kohnen R, Hiller K-O. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks [with commentary by K Linde and M Berner]. BMJ 1999; 319: 1534–1539. (11 December 1999.)
9. Harrer G, Schmidt U, Kuhn U, Biller A. Comparison of equivalence between St John's wort extract Lo Hyp-57 and fluoxetine. Arzneimittelforschung 1999; 49: 289–296.
10. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134–138.
11. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1988.
12. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression—an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253–258.
13. Vitiello B. Hypericum perforatum extracts as potential antidepressants. J Pharm Pharmacol 1999; 51: 513–517.
14. Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. Solubilised hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta medica 1998; 64: 291–294.